Fortress Biotech (FBIO) Net Margin: 2013-2025
Historic Net Margin for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to 20.84%.
- Fortress Biotech's Net Margin rose 12365.00% to 20.84% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.57%, marking a year-over-year increase of 8347.00%. This contributed to the annual value of -96.91% for FY2024, which is 1565.00% down from last year.
- According to the latest figures from Q3 2025, Fortress Biotech's Net Margin is 20.84%, which was down 74.38% from 81.37% recorded in Q2 2025.
- Over the past 5 years, Fortress Biotech's Net Margin peaked at 81.37% during Q2 2025, and registered a low of -341.20% during Q4 2021.
- In the last 3 years, Fortress Biotech's Net Margin had a median value of -89.55% in 2024 and averaged -73.54%.
- Per our database at Business Quant, Fortress Biotech's Net Margin crashed by 16,654bps in 2021 and then spiked by 17,092bps in 2025.
- Quarterly analysis of 5 years shows Fortress Biotech's Net Margin stood at -341.20% in 2021, then skyrocketed by 16,498bps to -176.22% in 2022, then surged by 11,963bps to -56.59% in 2023, then tumbled by 725bps to -63.84% in 2024, then surged by 12,365bps to 20.84% in 2025.
- Its Net Margin stands at 20.84% for Q3 2025, versus 81.37% for Q2 2025 and -96.77% for Q1 2025.